Methuselah Foundation
An American nonprofit that funds and develops research, prizes, and ventures aimed at extending healthy human lifespan and improving regenerative medicine.
Last updated October 14, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Methuselah Foundation is an American nonprofit organization headquartered in Springfield, Virginia, whose work centers on longevity science, regenerative medicine, tissue engineering, organ preservation, and related life-science innovation. Rather than operating primarily as a consumer-facing product brand, it functions as a funding, prize-making, convening, and venture-incubation platform. Its activities have included direct support for academic research, sponsorship of scientific initiatives, partnerships with government and nonprofit organizations, and investment in early-stage biotechnology companies. The organization was incorporated in 2001 by David Gobel under the name Performance Prize Society. In 2003, Gobel, Aubrey de Grey, and Dane Gobel adopted the Methuselah Foundation name. The name refers to Methuselah, the biblical figure traditionally described as having lived 969 years, and reflects the foundation's interest in the biological mechanisms of unusually long life. The rebranding was presented at the American Aging Association's annual meeting, where an award recognized Andrej Bartke's research on exceptionally long-lived mice. A major early focus was the Strategies for Engineered Negligible Senescence, or SENS, research framework associated with Aubrey de Grey. From 2003 through 2009, Methuselah served as the organizational base for SENS-related work, supporting research programs, scientific meetings, and collaborations at institutions including Rice University and Arizona State University. The SENS program sought to address several categories of molecular and cellular damage associated with aging. In 2009, the program separated from Methuselah and became the independent SENS Research Foundation. The foundation has also pursued the practical replacement and repair of biological systems. Through the New Organ Alliance and related work with the Organ Preservation Alliance, it supported efforts to reduce organ shortages and improve the preservation, fabrication, and regeneration of human organs. In 2013, it announced the New Organ Liver Prize, intended to encourage the development of a bioengineered or regenerative liver therapy. It also supported research using Organovo 3D bioprinting systems at academic centers, with initial participating institutions including Yale School of Medicine, UCSF School of Medicine, and the Murdoch Children's Research Institute. Methuselah has used challenge prizes to attract teams to difficult biomedical and space-related problems. In cooperation with NASA and the New Organ Alliance, it participated in the Vascular Tissue Challenge, which sought laboratory-grown, thick, metabolically functional vascularized human tissue. The initiative included a 2016 roadmapping workshop supported by the National Science Foundation. In 2021, Methuselah announced another NASA collaboration, the Deep Space Food Challenge, which recognized teams developing food-production technologies suitable for long-duration space missions. Its portfolio has extended beyond organ engineering. In 2006, the foundation contributed capital and fiscal sponsorship to help launch the Supercentenarian Research Foundation, focused on people who reach at least 110 years of age. In 2015, funding from Methuselah and the Life Extension Foundation supported sequencing of the bowhead whale genome, seeking clues from a mammal capable of living for more than two centuries. The organization created Methuselah Funds in 2017 to invest in early-stage life-science companies, adding a venture-building component to its grantmaking and prize activities. The foundation's funding history includes support from individual donors and technology and finance figures. Peter Thiel announced a pledge to the foundation and SENS programs in 2006, while the anonymous Pineapple Fund contributed to Methuselah in 2018. Vitalik Buterin made donations in 2021. The foundation has also participated in larger biomedical philanthropy, including a reported contribution to the Albert Einstein College of Medicine through its New Parts for People initiative. The organization's present identity is therefore that of a longevity-focused nonprofit ecosystem builder: it supports research, creates incentives through prizes, helps form specialized alliances, and seeks to accelerate commercialization of technologies that could repair, replace, or preserve human biological systems.
History
Methuselah Foundation began in 2001, when David Gobel incorporated the Performance Prize Society as a vehicle for using prizes and philanthropy to accelerate biomedical progress. In 2003, Gobel, Aubrey de Grey, and Dane Gobel renamed the organization Methuselah Foundation. The new identity invoked Methuselah, the biblical figure associated with extraordinary longevity, and was introduced at an American Aging Association meeting alongside recognition for Andrej Bartke's work on long-lived mice. During the 2000s, the foundation became closely associated with the SENS framework, which proposed repairing or reversing several forms of molecular and cellular damage that accumulate with age. From 2003 to 2009, Methuselah served as the backbone organization for SENS activities. It sponsored research programs in human bioremedial biology at Rice University and Arizona State University, as well as roundtables and conferences intended to develop the scientific case and practical methods for addressing age-related damage. In 2009, SENS separated from Methuselah and became the SENS Research Foundation. The organization also developed a second major line of work around replacing, regenerating, and preserving human organs. In 2006, it contributed capital and fiscal sponsorship to the creation of the Supercentenarian Research Foundation, which studies people aged 110 and older. In 2013, Methuselah sponsored the New Organ Alliance and announced the New Organ Liver Prize, designed to encourage a bioengineered or regenerative liver solution. It also collaborated with the Organ Preservation Alliance on technologies and policy related to reducing organ shortages. In the same period, Methuselah supported the application of 3D bioprinting to biomedical research. A 2013 partnership with Organovo directed funding toward academic institutions using bioprinting platforms, with Yale School of Medicine, UCSF School of Medicine, and the Murdoch Children's Research Institute identified as initial recipients. These programs reflected the foundation's practical emphasis on developing replacement tissues and organs rather than limiting its activity to basic aging research. The foundation's interests expanded into comparative genomics and extreme longevity. In 2015, Methuselah and the Life Extension Foundation funded sequencing of the bowhead whale genome. Because bowhead whales can live for more than 200 years, researchers hoped that the genome might reveal mechanisms connected to longevity and resistance to age-related disease. The resulting genome assembly was made available for further study. Methuselah has repeatedly used competitive prizes and public-private partnerships to address complex technical problems. In 2016, NASA and the New Organ Alliance announced the Vascular Tissue Challenge, which encouraged the creation of thick, functional vascularized human tissue. A related roadmapping workshop was held at NASA Research Park with support from the National Science Foundation. In 2017, Methuselah created Methuselah Funds, adding early-stage investment in life-science companies to its existing mix of grants, sponsorship, and prize programs. The organization later extended its NASA relationship to food production in space. Announced in 2021, the Deep Space Food Challenge sought technologies capable of producing food during long-duration space missions, and prizes were awarded to 18 U.S. teams. Methuselah has also participated in broader biomedical philanthropy, including support described under the New Parts for People initiative and a contribution to the Albert Einstein College of Medicine. Individual philanthropy has been important to Methuselah's development. The foundation has described early support from hundreds of donors, while publicized contributions included Peter Thiel's 2006 pledge to Methuselah and SENS activities, a 2018 donation from the anonymous Pineapple Fund, and donations from Vitalik Buterin in 2021. Across its history, the foundation has maintained a distinctive hybrid model: it funds research, convenes specialists, sponsors challenge prizes, supports nonprofit alliances, and invests in companies that may turn longevity and regenerative-medicine ideas into practical technologies.
- 2021
Deep Space Food Challenge collaboration announced
[1]Methuselah and NASA launched a challenge for food-production technologies suited to long-duration spaceflight.
- 2017
Methuselah Funds established
[1]The foundation created an investment vehicle for early-stage life-science companies.
- 2016
Vascular Tissue Challenge announced
[1]NASA and the New Organ Alliance launched a competition focused on functional vascularized human tissue.
- 2015
Bowhead whale genome supported
[1]Methuselah helped fund sequencing of the bowhead whale genome for longevity research.
- 2013
New Organ Liver Prize announced
[1]The New Organ Alliance introduced a prize to encourage regenerative or bioengineered liver therapies.
- 2013
Organovo research partnership begins
[1]Methuselah began funding academic use of Organovo 3D bioprinting systems for biomedical research.
- 2009
SENS becomes independent
[1]The SENS program spun out as the SENS Research Foundation.
- 2006
Supercentenarian Research Foundation launched with Methuselah support
[1]Methuselah contributed capital and fiscal sponsorship to establish a research organization focused on supercentenarians.
- 2003
Methuselah Foundation name adopted
[1]David Gobel, Aubrey de Grey, and Dane Gobel rebranded the organization as Methuselah Foundation.
- 2003
SENS support begins
[1]Methuselah became the backbone organization for the SENS research program.
Products and positioning
A mission-driven longevity and regenerative-medicine platform that combines nonprofit grantmaking, scientific collaboration, challenge prizes, and early-stage biotechnology investment.
Life-science investment platform · 2017
Methuselah Funds
Created in 2017, Methuselah Funds extends the foundation's mission into early-stage company investment. It is intended to identify and support businesses developing technologies relevant to longevity, regenerative medicine, tissue engineering, organ replacement, and related biomedical applications. The fund is not a consumer product line; it is an investment and venture-development mechanism within the foundation's broader nonprofit ecosystem.
Biomedical initiative · 2013
New Organ Alliance
The New Organ Alliance is an initiative sponsored by Methuselah to address shortages and limitations in human organ transplantation. Its activities have included prize design, partnerships, workshops, and support for regenerative and bioengineered organ technologies. The initiative's best-known effort was the New Organ Liver Prize, which sought to stimulate a viable liver-repair or liver-replacement solution.
Biomedical challenge prize · 2016
Vascular Tissue Challenge
The Vascular Tissue Challenge was developed with NASA and the New Organ Alliance to encourage the creation of thick, metabolically functional human tissue containing a working vascular network. The competition was intended to overcome a central obstacle in tissue engineering: keeping engineered tissue alive and functional at clinically meaningful thicknesses. A related technical roadmapping workshop brought researchers and stakeholders together to clarify the field's priorities.
Space food technology challenge · 2021
Deep Space Food Challenge
Methuselah's NASA collaboration on the Deep Space Food Challenge focused on systems that can produce nutritious food during long-duration space missions. The challenge connects food production, resource efficiency, controlled environments, and human health—areas that overlap with the foundation's interest in resilient biological systems. The program recognized 18 U.S. teams for food-production technology.
Longevity research program · 2003
SENS research program support
From 2003 to 2009, Methuselah provided organizational and financial support for the SENS framework, which proposed repairing several forms of molecular and cellular damage associated with aging. Support included research programs, scientific roundtables, conferences, and collaborations with academic institutions. The program later separated from the foundation and continued under the SENS Research Foundation.
Biomedical research grants · 2013
3D bioprinter academic grants
Beginning in 2013, Methuselah partnered with Organovo to support the use of 3D bioprinters in academic biomedical research. The program was designed to help research centers explore engineered tissues and model biological systems using printed cellular structures. Initial recipients included Yale School of Medicine, UCSF School of Medicine, and the Murdoch Children's Research Institute.
Marketing campaigns
- 2021Deep Space Food Challenge
United States
Methuselah collaborated with NASA on a competition for food-production technologies capable of supporting crews during long-duration space missions.
Outcome. Prizes were awarded to 18 U.S. teams, according to the referenced material.
- 2016Vascular Tissue Challenge
United States
Methuselah-associated New Organ Alliance partnered with NASA on a challenge seeking laboratory-grown vascularized human tissue with sufficient thickness and metabolic function for meaningful biomedical use.
Outcome. The challenge was accompanied by a roadmapping workshop at NASA Research Park. The referenced material does not establish a final winning team or completed clinical application.
Brand decisions
2017
Create Methuselah FundsStrategyBackground
The foundation's mission increasingly involved translating longevity and regenerative-medicine research into deployable technologies.
Action taken
Methuselah established an investment platform for early-stage life-science companies.
Aftermath
The foundation expanded from grants and challenge prizes into venture support and company building.
2009
Separate SENS into an independent organizationStrategyBackground
SENS had operated within Methuselah as a long-term research framework focused on repairing age-related molecular and cellular damage.
Action taken
The SENS program spun out from Methuselah and became the SENS Research Foundation.
Aftermath
Methuselah continued its own portfolio of longevity, organ-replacement, tissue-engineering, prize, and venture activities while SENS operated independently.
2003
Rebrand as Methuselah FoundationStrategyBackground
The organization sought a name aligned with its focus on unusually long life and aging research.
Action taken
David Gobel, Aubrey de Grey, and Dane Gobel replaced the Performance Prize Society name with Methuselah Foundation.
Aftermath
The new name became the foundation's continuing identity and was introduced alongside recognition of longevity research.
Recent events
- 2021
Methuselah joins NASA's Deep Space Food Challenge[1]
Other
The foundation announced a second NASA collaboration focused on food-production technologies for long-duration space missions; prizes were awarded to 18 U.S. teams.
- 2021
Vitalik Buterin makes donations to Methuselah Foundation[1]
Other
Ethereum co-founder Vitalik Buterin made a series of donations to the foundation.
- 2018
Pineapple Fund donates to Methuselah Foundation[1]
Other
The anonymous Pineapple Fund made a philanthropic contribution to Methuselah Foundation as part of its cryptocurrency-funded charitable giving.
- 2017
Methuselah Funds is created[1]
M&A
The foundation established Methuselah Funds to invest in early-stage life-science companies.
- 2016
NASA and New Organ Alliance announce Vascular Tissue Challenge[1]
Other
The challenge sought teams capable of producing thick, metabolically functional, vascularized human tissue in laboratory conditions.
- 2015
Bowhead whale genome project receives Methuselah support[1]
Other
Funding helped researchers sequence the bowhead whale genome to investigate biological traits associated with exceptional longevity and disease resistance.
- 2013
New Organ Liver Prize announced[1]
Other
The New Organ Alliance announced a prize intended to stimulate bioengineered or regenerative approaches to liver replacement and repair.
- 2013
Methuselah partners with Organovo on 3D bioprinting research[1]
Other
The foundation began supporting the use of Organovo's 3D bioprinting technology in academic biomedical research.
- 2009
SENS becomes an independent research foundation[1]
Other
The SENS program separated from Methuselah Foundation and continued as the independent SENS Research Foundation.
- 2006
Peter Thiel announces support for Methuselah and SENS[1]
Other
Peter Thiel announced philanthropic support for the Methuselah Foundation and SENS-related research.
Showing the 10 most recent.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/methuselah-foundation · Editorial policy · How profiles are compiled